The Advisory Board Company Reports Results For Quarter Ended June 30, 2015

Company Reports Revenue Growth of 30%, Contract Value Growth of 35%, and Announces Two New Programs

Aug 04, 2015, 16:25 ET from The Advisory Board Company

WASHINGTON, Aug. 4, 2015 /PRNewswire/ -- The Advisory Board Company (NASDAQ: ABCO), a global technology, research, and services company providing the leading cloud-based comprehensive performance platform for the health care and higher education industries, today announced financial results for the quarter ended June 30, 2015. 

Highlights from the second quarter of 2015 include (All comparisons, unless otherwise noted, are to the quarter ended June 30, 2014):

  • Revenue of $184.7 million, an increase of 30%
  • Adjusted revenue of $191.3 million, an increase of 35%
  • Contract value of $741.7 million, an increase of 35%
  • Adjusted EBITDA of $47.0 million, an increase of 96%
  • Non-GAAP earnings per diluted share of $0.40, an increase of 33%

Robert Musslewhite, Chairman and Chief Executive Officer of The Advisory Board Company, commented, 'The company continues to experience strong growth and momentum, as highlighted by our 35% adjusted revenue growth rate and our 96% adjusted EBITDA growth rate for the quarter. Our proven formula of renewable, scalable programs continues to yield solid revenue growth, robust earnings growth, and compelling margin expansion. As always, our focus on member impact drives our success, and we continue to deliver strong returns to each of our members and to the broader health care and higher education industries. Our 5,200 members regularly affirm that, and the 93% member renewal rate we earned this year, the highest in our history, is a testament to the positive impact our work has on their most pressing issues."

Mr. Musslewhite continued, "Growth is a function of innovation, and, as always, we continue to innovate. I am pleased to announce two new product launches, Audience Rx in health care and Navigate in higher education. Audience Rx is a renewable, cloud-based technology offering that provides our health care members a cutting-edge solution to enable data-driven, targeted digital marketing that will equip them with the capabilities that large consumer brands use to engage and drive loyalty with their customers. The solution helps hospitals understand their data on patient interactions and better connect with their communities by unlocking insights about their relevant audience segments customized to health needs."

Mr. Musslewhite concluded, "Navigate is also a renewable, cloud-based technology product that provides community colleges a student success solution targeted specifically to the challenges facing their unique student bodies. The average community college loses 50% of student applicants between the point of student application and the first day of class due to challenges with the college transition. Navigate initially acts as a personal compass for students during onboarding, helping them pick a program based on job data, creating an academic plan that maximizes their chance of graduating, and developing a personalized school schedule that helps balance school and life. The platform then stays with students throughout their time in college, acting as the term-over-term interface between the college and student and helping students succeed and graduate. Both new programs are off to a strong start, and we are excited about the impact they will have for our members."

Second Quarter Financial Review

Revenue increased 30% to $184.7 million in the quarter ended June 30, 2015 up from to $141.8 million for the quarter ended June 30, 2014. Adjusted revenue, which adjusts for the effect on revenue of fair value adjustments to acquired deferred revenue, increased 35% to $191.3 million for the quarter ended June 30, 2015, up from $141.8 million for the quarter ended June 30, 2014. Contract value increased 35% to $741.7 million as of June 30, 2015, up from $548.4 million as of June 30, 2014.

Net income attributable to common stockholders was $8.7 million, or $0.20 per diluted share, for the quarter ended June 30, 2015, compared to net loss attributable to common stockholders of $3.2 million, or $0.09 per diluted share, for the quarter ended June 30, 2014. Adjusted net income increased 56% to $17.1 million for the quarter ended June 30, 2015, up from $11.0 million for the quarter ended June 30, 2014. Non-GAAP earnings per diluted share increased 33% to $0.40 for the quarter ended June 30, 2015 up from $0.30 for the quarter ended June 30, 2014.

Adjusted EBITDA increased 96% to $47.0 million for the quarter ended June 30, 2015, up from $24.0 million for the quarter ended June 30, 2014.

Adjusted revenue, adjusted net income, non-GAAP earnings per diluted share, and adjusted EBITDA are non-GAAP financial measures.

Year-to-Date Financial Review

Revenue increased 30% to $364.5 million for the six month period ended June 30, 2015, up from $279.8 million for the six month period ended June 30, 2014. Adjusted revenue increased 35% to $377.0 million for the six month period ended June 30, 2015, up from $279.8 million for the six month period ended June 30, 2014. Net loss attributable to common stockholders was $15.0 million, or $0.36 per diluted share, for the six month period ended June 30, 2015, compared to net income attributable to common stockholders of $5.1 million, or $0.14 per diluted share, for the six month period ended June 30, 2014. Adjusted EBITDA was $86.5 million for the six month period ended June 30, 2015, up from $50.0 million for the six month period ended June 30, 2014. Adjusted net income was $30.1 million for the 2015 six month period ended June 30, 2015, up from $23.7 million for the six month period ended June 30, 2014. Non-GAAP earnings per diluted share were $0.71 for the six month period ended June 30, 2015, up from $0.64 for the six month period ended June 30, 2014.

Outlook for Calendar Year 2015 

The Company is updating its annual financial guidance. For calendar year 2015, the Company expects:

  • Adjusted revenue to be in a range of approximately $780 million to $790 million, revised from the previous range of approximately $780 million to $800 million
  • Adjusted EBITDA to be in a range of approximately $170 million to $175 million, revised from the previous range of approximately $170 million to $180 million
  • Non-GAAP earnings per diluted share to be in a range of approximately $1.30 to $1.37, revised from the previous range of approximately $1.30 to $1.43
  • Adjusted effective tax rate (a non-GAAP financial measure) to be in a range of approximately 45% to 47%

The Company is also providing financial guidance for the quarter ending September 30, 2015. For the quarter ending September 30, 2015, the Company expects:

  • Adjusted revenue to be in a range of approximately $187 million to $191 million
  • Adjusted EBITDA to be in a range of approximately $27 million to $29 million
  • Non-GAAP earnings per diluted share to be in a range of approximately $0.12 to $0.15

Conference Call Information

As previously announced, the Company will hold a conference call to discuss its second quarter performance this evening, August 4, 2015, at 5:30 p.m. Eastern Time. The conference call will be available via live webcast on the Company's website at www.advisory.com/IR. To participate by telephone, the dial-in number is 888.336.7150. Participants are advised to dial in at least five minutes prior to the call to register. The webcast will be archived for seven days from 8:00 p.m. Eastern Time on Tuesday, August 4, 2015, until 11:00 p.m. Eastern Time on Tuesday, August 11, 2015. The Company invites all interested parties to attend the conference call, including the lenders under the Company's senior secured credit facilities. 

A supplemental presentation of information complementary to the information presented in this release and that will be discussed on the conference call will be made available on the Company's website at www.advisory.com/IR prior to the conference call and will be archived for the same duration as the webcast.

About the Advisory Board Company

The Advisory Board Company is the leading provider of insight-driven technologyresearch, and services for organizations in transforming industries. Through its innovative membership model, the Company collaborates with more than 230,000 leaders at 5,200 member organizations to elevate performance and solve their most pressing problems. The Company provides strategic guidance, actionable insights, cloud-based software solutions, and comprehensive implementation and management services. For more information, visit www.advisory.com.

Non-GAAP Financial Measures 

This news release presents information about the Company's adjusted revenue, adjusted net income, non-GAAP earnings per diluted share, adjusted EBITDA, adjusted effective tax rate, and adjusted weighted average common shares outstanding-diluted, which are non-GAAP financial measures provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of each of the foregoing historical non-GAAP financial measures to the most directly comparable historical GAAP financial measures is provided in the accompanying tables found at the end of this release for each of the fiscal periods indicated.

Caution Regarding Forward-Looking Statements

Statements in this news release that relate to future results and events are forward-looking statements and are based on the Company's expectations as of the date of this news release. In some cases, you can identify these statements by such forward-looking words as "anticipate," "believe," "estimate," "expect," "guidance," "intend," "may," "outlook," "plan," "potential," "should," "will," "would," or similar words or expressions. Forward-looking statements in this news release include the Company's expectations regarding its performance and results for fiscal 2015 with respect to adjusted revenue, adjusted EBITDA,  non-GAAP earnings per diluted share, and adjusted effective tax rate. 

Actual results and events in future periods may differ materially from those expressed or implied by these forward-looking statements because of a number of risks, uncertainties, and other factors, including those relating to:  factors that adversely affect the financial condition of the health care and higher education industries; federal and state law and regulations governing the health care and higher education industries and our members' and our respective compliance with those applicable laws and regulations; the Company's ability to sustain high renewal rates on its memberships; maintenance of the Company's reputation and expansion of its name recognition; the Company's ability to offer new and valuable products and services; effects of competition; the Company's ability to maintain a highly-skilled workforce; unsuccessful design or implementation of software or delivery of consulting and management services; delays in generating revenue; effects of federal and state privacy and security laws and cyber attacks and other data security breaches; compliance with federal regulations governing electronic transactions; service disruptions and operational or security failures; ability to collect and maintain member and third party data and to obtain proper permissions and waivers for use and disclosure of information received from members or on their behalf; liability for failure to provide accurate information or for deficient submissions to third-party payors; compliance with federal and state laws governing healthcare fraud and abuse or reimbursement; maintenance of third-party providers and strategic alliances and entry into new alliances; licensing and integration of third-party technologies and data; protection of the Company's intellectual property; claims of infringement, misappropriation, or violation of proprietary rights of third parties; limitations associated with use of open source technology; changes to estimates and assumptions used to prepare the Company's consolidated financial statements; any significant increase in bad debt in excess of recorded estimates; failure to realize the anticipated benefits of the Royall acquisition; diversion of management's attention from operations by activities focused on the integration of Royall's business; business and financial risk associated with the pursuit of acquisition opportunities; delays in the delivery by Evolent Health to the Company of its financial statements; any significant impairment of the Company's goodwill; the Company's ability to realize a return on its strategic investments; the level of the Company's debt service obligations and restrictions on its operations under debt covenants; potential imposition of sales and use taxes on sales of the Company's services; the Company's ability to realize fully its deferred tax assets; inherent limitations in, and the potential impact of any failure to maintain, effective internal control over financial reporting; effects of issuance of additional capital stock; and provisions in the Company's charter and bylaws that could discourage takeover attempts.

This list of risks, uncertainties, and other factors is not complete. The Company discusses some of these matters more fully, as well as certain risk factors that could affect the Company's business, financial condition, results of operations, and prospects, in its filings with the Securities and Exchange Commission, including the Company's annual report on form 10-KT for the transition period ended December 31, 2014 and its quarterly reports on Form 10-Q and current reports on Form 8-K. These filings are available for review through the Securities and Exchange Commission's website at www.sec.gov. Any or all forward-looking statements the Company makes may turn out to be wrong, and can be affected by inaccurate assumptions the Company might make or by known or unknown risks, uncertainties, and other factors, including those identified in this news release. Accordingly, you should not place undue reliance on the forward-looking statements made in this news release, which speak only as of its date. The Company does not undertake to update any of its forward-looking statements, whether as a result of circumstances or events that arise after the date they are made, new information, or otherwise.

THE ADVISORY BOARD COMPANY

 UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

 AND OTHER OPERATING STATISTICS

 (In thousands, except per share data)

 Three Months Ended

 Selected

 Six Months Ended

 Selected

 June 30,

 Growth

 June 30,

 Growth

2015

2014

 Rates

2015

2014

 Rates

 Statements of Income

 Revenue (1)

$    184,661

$    141,820

30.2%

$    364,456

$     279,821

30.2%

 Cost of services, excluding depreciation and amortization (2) (3)

92,221

74,218

187,528

141,413

 Member relations and marketing (2)

29,375

26,576

60,101

52,988

 General and administrative (2) (4) (5)

30,853

22,712

62,527

41,455

 Depreciation and amortization (6)

19,499

9,078

36,573

17,546

      Operating income

12,713

9,236

17,727

26,419

 Other (expense) income

      Interest expense

(5,154)

-

(10,766)

-

      Other (expense) income, net

(128)

710

(1,247)

1,442

      Loss on financing activities

-

-

(17,398)

-

 Total other (expense) income, net

(5,282)

710

(29,411)

1,442

      Income (loss) before provision for income taxes

        and equity in income / (loss) of unconsolidated entities

7,431

9,946

(11,684)

27,861

 Provision for income taxes

(2,716)

(3,933)

(4,910)

(10,830)

 Equity in income / (loss) of unconsolidated entities

4,000

(2,150)

1,621

(4,881)

      Net income (loss) before allocation to noncontrolling interest

8,715

3,863

(14,973)

12,150

 Net loss and accretion to redemption value of noncontrolling interest

-

(7,040)

-

(7,040)

      Net income (loss) attributable to common stockholders

$        8,715

$      (3,177)

$    (14,973)

$         5,110

 Net (loss) income attributable to common stockholders per share

      Basic

$          0.21

$        (0.09)

$        (0.36)

$           0.14

      Diluted

$          0.20

$        (0.09)

$        (0.36)

$           0.14

 Weighted average common shares outstanding

      Basic

42,440

36,413

41,686

36,310

      Diluted

42,914

36,413

41,686

37,125

 Contract Value (at end of period) 

$    741,673

$    548,379

35.2%

 Percentages of Revenue

 Cost of services, excluding depreciation and amortization (2) (3)

49.9%

52.3%

51.5%

50.5%

 Member relations and marketing (2)

15.9%

18.7%

16.5%

18.9%

 General and administrative (2) (4) (5)

16.7%

16.0%

17.2%

14.8%

 Depreciation and amortization (6)

10.6%

6.4%

10.0%

6.3%

 Operating income

6.9%

6.5%

4.9%

9.4%

 Net income attributable to common stockholders

4.7%

-2.2%

-4.1%

1.8%

(1)

Amounts include effect on revenue of fair value adjustments to acquisition-related deferred revenue, as follows:

Revenue

(6,617)

-

(12,499)

-

(2)

Amounts include stock-based compensation, as follows:

Cost of services

2,566

2,089

4,458

3,471

Member relations and marketing

1,455

1,081

2,601

1,924

General and administrative

4,610

2,371

7,977

4,569

(3)

Amounts include fair value adjustments of acquisition-related earn-out liabilities, as follows:

Cost of services

(1,427)

(100)

(1,083)

(4,200)

(4)

Amounts include acquisition and transaction related costs, as follows:

General and administrative

961

268

6,610

268

(5)

Amounts include reversal of vacation accrual charge related to change in fiscal year as follows:

General and administrative

-

-

(850)

-

(6)

Amounts include amortization of acquisition-related intangibles, as follows:

Depreciation and amortization

8,031

2,401

15,580

4,728

 

THE ADVISORY BOARD COMPANY

 CONSOLIDATED BALANCE SHEETS

 (In thousands)

June 30,

December 31,

2015

2014

 (unaudited)

 ASSETS

 Current assets:

 Cash and cash equivalents

$               49,550

$               72,936

 Marketable securities, current

-

14,714

 Membership fees receivable, net

603,173

539,061

 Prepaid expenses and other current assets

34,033

23,254

 Deferred income taxes, current

16,035

14,695

 Total current assets

702,791

664,660

 Property and equipment, net

178,690

135,107

 Intangible assets, net

290,744

38,973

 Deferred incentive compensation and other charges

86,351

86,045

 Goodwill

840,809

186,895

 Investments in unconsolidated entities

5,680

9,316

 Other non-current assets

5,698

5,370

 Total assets

$          2,110,763

$          1,126,366

 LIABILITIES AND STOCKHOLDERS' EQUITY

 Current liabilities:

 Deferred revenue, current

$             563,349

$             501,785

 Accounts payable and accrued liabilities

71,191

80,284

 Accrued incentive compensation

20,042

32,073

 Debt, current

27,880

-

 Total current liabilities

682,462

614,142

 Deferred revenue, net of current portion

168,854

167,014

 Deferred income taxes, net of current portion

121,899

9,855

 Debt, net of current portion

536,395

-

 Other long-term liabilities

10,136

15,304

 Total liabilities

1,519,746

806,315

 Stockholders' equity:

 Common stock

425

361

 Additional paid-in capital

727,289

442,528

 Accumulated deficit

(137,893)

(122,920)

 Accumulated other comprehensive income

1,196

82

 Total stockholders' equity 

591,017

320,051

 Total liabilities and stockholders' equity

$          2,110,763

$          1,126,366

 

THE ADVISORY BOARD COMPANY

 UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

 (In thousands)

 Six Months Ended June 30,

2015

2014

 Cash flows from operating activities:

 Net (loss) income before allocation to noncontrolling interest

$     (14,973)

$       12,150

 Adjustments to reconcile net (loss) income before allocation to 

 noncontrolling interest to net cash provided by operating activities:

 Depreciation and amortization

36,573

17,546

 Loss on financing activities

17,398

-

 Amortization of debt issuance costs

703

-

 Deferred income taxes

11,356

9,806

 Excess tax benefits from stock-based awards

(2,483)

(7,900)

 Stock-based compensation expense

15,036

9,964

 Amortization of marketable securities premiums

-

1,235

 (Gain) loss on investment in common stock warrants

(70)

180

 Equity in (income) loss of unconsolidated entities

(1,621)

4,881

 Changes in operating assets and liabilities (net of the effect of acquisition):

 Membership fees receivable

(34,872)

(10,953)

 Prepaid expenses and other current assets

(178)

(5,336)

 Deferred incentive compensation and other charges

870

3,801

 Other non-current assets

(258)

-

 Deferred revenue

45,104

(7,406)

 Accounts payable and accrued liabilities

(10,949)

1,069

 Acquisition-related earn-out payments

(1,948)

(2,798)

 Accrued incentive compensation

(12,031)

(13,700)

 Other long-term liabilities

(5,168)

(7,207)

 Net cash flows provided by operating activities

42,489

5,332

 Cash flows from investing activities:

 Purchases of property and equipment

(23,783)

(20,331)

 Capitalized external use software development costs

(2,181)

(2,689)

 Cash paid for acquisitions, net of cash acquired

(744,193)

(25,830)

 Cash paid for investment in unconsolidated entity

(3,006)

-

 Redemptions of marketable securities

14,714

81,669

 Purchases of marketable securities

-

(32,510)

 Net cash flows (used in) provided by investing activities

(758,449)

309

 Cash flows from financing activities:

 Proceeds from debt, net

1,280,292

-

 Pay down of debt

(732,189)

-

 Debt issuance costs

(2,568)

-

 Proceeds from issuance of common stock, net of selling costs

148,786

-

 Proceeds from issuance of common stock from exercise of stock options

3,014

5,810

 Withholding of shares to satisfy minimum employee tax withholding

(6,007)

(7,735)

 Proceeds from issuance of stock under employee stock purchase plan

263

296

 Contributions from noncontrolling interest

-

200

 Acquisition-related earn-out payments

(1,500)

-

 Excess tax benefits from stock-based awards

2,483

7,900

 Purchases of treasury stock

-

(23,772)

 Net cash flows provided by (used in) financing activities

692,574

(17,301)

 Net decrease in cash and cash equivalents

(23,386)

(11,660)

 Cash and cash equivalents, beginning of period

72,936

52,717

 Cash and cash equivalents, end of period

$       49,550

$       41,057

 

Reconciliation of Non-GAAP Financial Measures

This news release presents information about the Company's adjusted revenue, adjusted EBITDA, adjusted net income, non-GAAP earnings per diluted share, adjusted effective tax rate, and adjusted weighted average common shares outstanding-diluted, which are non-GAAP financial measures provided as a complement to the results provided in accordance with GAAP.

A reconciliation of each of the foregoing historical non-GAAP financial measures to the most directly comparable historical GAAP financial measures is provided below for each of the fiscal periods indicated. It is not practicable to provide a reconciliation of forecasted adjusted revenue, adjusted EBITDA, adjusted net income, non-GAAP earnings per diluted share, or adjusted effective tax rate to the most directly comparable GAAP financial measures because certain items required for the forecast of such GAAP financial measures, including fair value adjustments to acquisition-related earn-out liabilities, equity in income  (loss) of unconsolidated entity, and gains and losses on investment in common stock warrants, cannot reasonably be estimated or predicted at this time.

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014

Revenue

$   184,661

$   141,820

$    364,456

$   279,821

Effect on revenue of fair value adjustments to acquisition-related deferred revenue

6,617

12,499

     Adjusted revenue

$   191,278

$   141,820

$    376,955

$   279,821

 

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014

Net income (loss) attributable to common stockholders

$    8,715

$   (3,177)

$    (14,973)

$     5,110

Effect on revenue of fair value adjustments to acquisition-related deferred revenue

6,617

12,499

Equity in (income)  loss of unconsolidated entities

(4,000)

2,150

(1,621)

4,881

Accretion of noncontrolling interest to redemption value

7,040

7,040

Provision for income taxes

2,716

3,933

4,910

10,830

Interest expense

5,154

10,766

Other expense (income), net

128

(710)

1,247

(1,442)

Loss on financing activities

17,398

Depreciation and amortization

19,499

9,078

36,573

17,546

Acquisition and similar transaction charges

961

268

6,610

268

Fair value adjustments to acquisition-related earn-out liabilities

(1,427)

(100)

(1,083)

(4,200)

Vacation accrual adjustment

(850)

Stock-based compensation expense

8,631

5,541

15,036

9,964

     Adjusted EBITDA

$    46,994

$   24,023

$     86,512

$    49,997

 

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014

Net income (loss) attributable to common stockholders

$    8,715

$    (3,177)

$    (14,973)

$     5,110

Effect of adjusted tax rate on net (loss) income

(494)

10,130

Effect on revenue of fair value adjustments to acquisition-related deferred revenue, net of adjusted tax rate

3,759

7,047

Equity in (income) loss of unconsolidated entities

(4,000)

2,150

(1,621)

4,881

Accretion of noncontrolling interest to redemption value

7,040

7,040

Amortization of acquisition-related intangibles, net of adjusted tax rate

4,562

1,452

8,782

2,883

Loss on financing activities, net of adjusted tax rate

9,725

Acquisition and similar transaction charges, net of adjusted tax rate

546

162

3,704

162

Fair value adjustments to acquisition-related earn-out liabilities, net of adjusted tax rate

(811)

(61)

(619)

(2,583)

(Gain) loss on investment in common stock warrants, net of adjusted tax rate

(40)

108

(40)

108

Vacation accrual adjustment, net of adjusted tax rate

(475)

Stock-based compensation expense, net of adjusted tax rate

4,902

3,351

8,482

6,071

Adjusted net income

$    17,139

$    11,025

$   30,142

$    23,672

 

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014

Net income (loss) attributable to common shareholders per share - Diluted

$    0.20

$   (0.09)

$    (0.36)

$    0.14

Effect of adjusted tax rate on net (loss) income

(0.01)

0.24

Effect on revenue of fair value adjustments to acquisition-related deferred revenue, net of adjusted tax rate

0.09

0.17

Equity in (income) loss of unconsolidated entities

(0.09)

0.06

(0.04)

0.13

Accretion of noncontrolling interest to redemption value

0.19

0.19

Amortization of acquisition-related intangibles, net of adjusted tax rate

0.11

0.04

0.21

0.08

Loss on financing activities, net of adjusted tax rate

0.23

Acquisition and similar transaction charges, net of adjusted tax rate

0.01

0.01

0.09

Fair value adjustments to acquisition-related earn-out liabilities, net of adjusted tax rate

(0.02)

(0.02)

(0.07)

Gain (loss) on investment in common stock warrants, net of adjusted tax rate

Vacation accrual adjustment, net of adjusted tax rate

(0.01)

Stock-based compensation expense, net of adjusted tax rate

0.11

0.09

0.20

0.17

Non-GAAP earnings per diluted share

$    0.40

$    0.30

$    0.71

$    0.64

 

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014

Effective tax rate

36.5%

39.5%

(42.0%)

38.9%

Effect on tax rate of Washington, D.C. tax law change, including write-off of Washington, D.C. income tax credits

91.3%

Effect on tax rate of loss on financing activities

0.9%

(8.5%)

Effect on tax rate of unconsolidated equity method investment related FIN 48 liability

(3.5%)

Effect on tax rate of Royall acquisition costs and other acquisition-related tax items

9.3%

2.8%

     Adjusted effective tax rate

43.2%

39.5%

43.6%

38.9%

 

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014

Weighted average common shares outstanding – Diluted

42,914

36,413

41,686

37,125

Diluted shares outstanding (1)

628

555

Adjusted weighted average common shares outstanding – Diluted

42,914

37,041

42,241

37,125

(1) For non-GAAP purposes the Company has net income, therefore has included diluted shares in its calculation of non-GAAP EPS.

 

Logo - http://photos.prnewswire.com/prnh/20110802/PH45999LOGO

 

SOURCE The Advisory Board Company



RELATED LINKS

http://www.advisory.com